- CVS obesity drug deal puts Lilly on equal footing with Novo<figure><div><img src="https://imgproxy.divecdn.com/LUU4XfIR8eFQgmY5HrlCjsI3-Klo8riH1u1jZ_W_2D4/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9MaWxseV9PRkdfQm90dGxlX1RhYmxldF9HM…BioPharma Dive · 1mo ago↗ source
- BioMarin drug acquired in buyout misses goal in rare disease study<figure><div><img src="https://imgproxy.divecdn.com/eghZalcvmA2hgw6MaT-fv8r1ksNzwZmQfKmkMEAO6pE/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjg5Nzg0NjQwLmpwZ…BioPharma Dive · 2mo ago↗ source
- A migraine drugmaker heads to the public markets through reverse merger<figure><div><img src="https://imgproxy.divecdn.com/0Yf4L7bvFRwsrMG85EgRSmundmb9MCnHWX_B23e8BPk/g:nowe:0:0/c:3000:1694/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0…